DanCann Pharma A/S: The subscription price for warrants of series TO 2 has been set
COPENHAGEN, Denmark, 15 May 2023 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby announces the subscription price for the exercise of warrants of series TO 2, which were issued in connection with the Company’s rights issue of units that was announced on 21 October 2022. The subscription price for all warrants of series TO 2 has been set at DKK 0.36 per share and the exercise period begins on 16 May 2023.Information about warrants of series TO 2 In connection with the Company’s rights issue of units that was announced